Dallas, TX (PRWEB) August 24, 2012
The patient advocates at the Pradaxa Resource Center are alerting those prescribed the blood thinner Pradaxa that FDA is investigating the drug’s association with severe internal bleeding. The recent decision of a federal judge will allow those injured to proceed with lawsuits.
Anyone who has suffered internal bleeding or had a loved one affected by taking Pradaxa is encouraged to speak with a lawyer about their legal rights as soon as possible.
Pradaxa is a popular anticoagulant drug prescribed to stop strokes and blood clots in patients with atrial fibrillation. Although only on the market since October, 2010, the drug has earned over $1 billion for manufacturer Boehringer Ingelheim in the year ending February, 2012, according to a Wall Street Journal report on April 24, 2012.
On December 7, 2011, the FDA warned that it would launch an investigation into Pradaxa after receiving more injury or death reports than expected. Reuters originally reported in November that the drug maker admitted to around 260 internal bleeding deaths among users.
Now, USA Today reports on August 19, 2012 that the FDA actually received 3,781 reports of side effects of Pradaxa and 542 deaths among users last year.
Due to the number of Pradaxa lawsuits expected, a central court was recently established in Illinois to handle the claims. The case is known as MDL No. 2385, IN RE: Pradaxa Product Liability Litigation, Southern District of Illinois. On July 25th, Judge David Herndon issued an order denying attempts by Boehringer Ingelheim to dismiss Pradaxa bleeding lawsuits.
Anyone affected by internal bleeding after Pradaxa use is urged to speak with a lawyer about their legal options. Due to the specialized nature of these federal MDL cases, the Pradaxa Resource center only recommends lawyers who are already handling Pradaxa lawsuits.
For more information on the research, warnings, Pradaxa side effects and legal options relating to the drug Pradaxa, or to speak with a lawyer, visit http://www.Pradaxa-lawsuits.org.
For the original version on PRWeb visit: http://www.prweb.com/releases/prwebpradaxa-side-effects/side-effects-of-pradaxa/prweb9831259.htm